3.15 (m, 2H), 2.90-2.70 (m, 2H), 2.58-2.35 (m, 2H), 2.25-2.08
(m, 1H), 1.36 (s, 9H), 1.35-1.00 (m, 3H).
57.3, 52.7, 15.8. Anal. Calcd for C19H25NO4: C, 68.86; H, 7.60;
N, 4.23. Found: C, 68.68; H, 7.74; N, 4.30.
E n a n t ioselect ive Alk yla t ion of 2c w it h Qu in in e a s a
Liga n d . Mehtod A was followed with 0.8 g of 2c and 1a to give
4g in 85% ee. The crude product was chromatographed on silica
gel, eluting with hexanes/EtOAC (4:1), to give 0.97 g (76%) of
4g as a white solid. Mp 80-85 °C. 1H NMR (CDCl3) δ 8.32 (d, J
) 3.8 Hz, 1 H), 7.39 (d, J ) 1.4 Hz, 1H), 7.29 (d, J ) 7.5 Hz,
1H), 7.05 (s, 1H), 7.00 (dd, J ) 7.5, 3.8 Hz, 1H), 4.85 (d, J )
10.3 Hz, 1H), 4.00 (br s, 2H), 3.58 (td, J ) 14.3, 2.6 Hz, 1H),
3.23-3.19 (m, 1H), 3.00-2.80 (m, 1H), 2.78-2.60 (m, 1H), 2.46
(br s, 2H), 2.35-2.15 (m, 2H), 1.36 (br s, 9H), 1.34-1.20 (m, 3H).
13C NMR (CDCl3) δ 156.8, 155.1, 146.8, 143.4, 139.7, 138.4,
133.6, 133.1, 131.2, 129.5, 127.6, 122.4, 79.7, 59.3, 42.6, 32.6,
32.5, 31.8, 30.8, 28.8. MS (MH+): 491. Calcd for C24H29BrClN2O2
(MH+): 491.
Con ver sion of 4-sa lt to 8. To a 500-mL flask were sequen-
tially charged 10 g (14.4 mmol) of 4-salt, 100 mL of toluene, 50
mL of 25% NaOH, and 100 mL of water. The resulting mixture
was agitated for 30 min and 1 g of Celite was added. The mixture
was filtered and washed with 10 mL of toluene. The layers were
separated and the organic layer was washed with 4 × 50 mL of
water. To the organic layer were added 40 mL of DMF, 0.20 g
(14.7 mmol) of 1-hydroxybenzotriazole (HOBT), 3.2 g (16.6 mmol)
of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide/HCl (EDCl/Cl),
and 4.0 g of 1-N-tert-butoxy-carbonylpiperidinyl-4-acetic acid.
The mixture was stirred at room temperature to completion
(about 18 h) as monitored by HPLC. To the reaction mixture
was added 50 mL of water and the layers were separated. The
organic layer was sequentially washed with 20 mL of 10% acetic
acid solution, 40 mL of water, 3% NaOH solution, 3 × 40 mL of
water, and 40 mL of brine. The organic layer was concentrated
to 60 mL and chromatographed on silica gel, eluting with EtOAc/
toluene (1:1). The fractions containing the product were com-
bined, concentrated, and treated with 3.5 g of activated basic
alumina. The mixture was filtered and washed with toluene.
The filtrate was concentrated and treated with EtOAc and
heptane to give after filtration 8.0 g (80%) of 8 as a solid. Mp
171-173 °C. 1H NMR (CDCl3) δ 8.44 (d, J ) 2.0 Hz, 1H), 7.55
(dd, J ) 5.0, 2.0 Hz, 1H), 7.49 (t, J ) 2.0 Hz, 1H), 4.89 (dd, J )
10.3, 3.5 Hz, 1H), 4.63-4.57 (m, 1H), 4.18-3.98 (m, 2H), 3.82
(t, J ) 12.7 Hz, 1H), 3.64 (tt, J ) 13.8, 3.6 Hz, 1H), 3.60 (dt, J
) 17.7, 4.3 Hz, 1H), 2.98 (tt, J ) 13.8, 3.6 Hz, 1H), 2.90-2.75
(m, 2H), 2.75-2.60 (m, 2H), 2.45-2.30 (m, 2H), 2.30-2.15 (m,
2H), 2.05-1.90 (m, 1H), 1.80-1.20 (m, 6H), 1.45 (s, 9H), 1.20-
1.05 (m, 2H).
Con ver sion of 8 to Lon a fa r n ib. To a 250-mL flask were
added 7.07 g (10.2 mmol) of 8 and 35 mL of ethanol. To the above
solution was added slowly 42 mL of 3 N HCl while maintaining
the temperature below 25 °C with an ice bath. The mixture was
stirred at room temperature for about 6 h to complete the
hydrolysis. The reaction mixture was concentrated under vacuum
to about 35 mL. To the concentrated mixture was added 17.5
mL of 1-methyl-2-pyrrolidinone and the pH was carefully
adjusted to 9 with 3 N NaOH. To the resulting mixture was
added 28.0 g of urea. The mixture was heated to 110 °C for about
10 h and cooled to 50 °C. The pH of the reaction mixture was
adjusted to 6 with 3 N HCl. The precipitate was filtered and
washed with 140 mL of water to give after drying 5.44 g (84%)
of Lonafarnib. Mp 222-223 °C. δ 1H NMR (CDCl3) 8.38 (d, J )
2.2 Hz, 1H), 7.48 (dd, J ) 4.8, 2.0 Hz, 1H), 7.43 (d, J ) 2.0 Hz,
1H), 7.08 (d, J ) 2.2 Hz, 1H), 4.82 (dd, J ) 10.3, 4.2 Hz, 1H),
4.53 (t, J ) 7.4 Hz, 1H), 4.34 (s, 2H), 3.90-3.70 (m, 3H), 3.55
(tt, J ) 13.8, 4.3 Hz, 1H), 3.20 (dt, J ) 17.6, 4.2 Hz, 1H), 2.95-
2.82 (m, 1H), 2.80-2.70 (m, 4H), 2.37-2.30 (m, 2H), 2.20-2.15
(m, 2H), 2.00-1.95 (m, 1H), 1.70 (d, J ) 12.8 Hz, 2H), 1.48-
1.00 (m, 6H). 13C NMR (CDCl3, two rotamers) 169.5, 158.3, 155.1,
155.0, 146.8, 144.1, 144.1, 137.8, 137.7, 136.3, 136.2, 132.4, 130.4,
129.8, 129.7, 126.7, 126.7, 118.8, 58.3, 58.2, 45.4, 45.3, 43.9, 41.4,
41.2, 40.8, 39.0, 38.9, 33.1, 32.7, 32.0, 31.8, 31.4, 31.3, 30.8, 30.6.
Anal. Calcd for C27H31Br2ClN4O2: C, 50.76; H, 4.89; N, 8.77.
Found C, 50.84; H, 4.77; N, 8.73.
En a n tioselective Alk yla tion w ith Qu in in e to 4b, 4c, a n d
4d . These alkylation products were all converted to the free
amine 4 for charaterization.
Alk yla tion w ith Cycloh exyl Mesyla te w ith Qu in in e to
4e. Mehtod A was followed and 4e was isolated with silica gel
column, eluting with hexanes/ethyl acetate (1:1) to give the
alkylated product as a white solid in 65% ee. Mp 165-167 °C.
1H NMR (CDCl3) δ 8.36 (d, J ) 2.2 Hz, 1H), 7.44 (dd, J ) 2.2,
1.1 Hz, 1H), 7.03 (d, J ) 2.2 Hz, 1H), 4.77 (d, J ) 10.3 Hz, 1H),
3.59 (td, J ) 13.2, 4.5 Hz, 1H), 3.34 (dt, J ) 17.4, 4.5 Hz, 1H),
2.88 (td, J ) 13.2, 4.7 Hz, 1H), 2.69 (dt, J ) 14.8, 4.7 Hz, 1H),
2.12-2.04 (m, 1H), 1.70-1.23 (m, 4H), 1.22-0.95 (m, 6H). 13C
NMR (CDCl3) δ 156.5, 147.5, 142.9, 141.6, 138.8, 135.4, 133.0,
131.2, 129.4, 127.6, 119.0, 59.3, 43.9, 32.7, 32.3, 32.0, 31.8, 27.0,
26.8, 26.5. MS (MH+): 468. Calcd for C20H21Br2ClN (MH+): 468.
Meth od B. En a n tioselective Alk yla tion w ith Nor ep h e-
d r in -Ba sed Liga n d 6d to 4a . The tricyclic methylene com-
pound 2a (50 g, 0.13 mol), trimethoxybenzyl-norephedrine ligand
6d (77 g in 436 mL of toluene solution, 1.8 equiv), and N-Boc
piperidine mesylate 1a (43.2 g, 1.2 equiv) were dissolved in
toluene (1 L). To the mixture at between 0 and 5 °C were
sequentially added lithium diisopropyl amide mono(tetrahydro-
furan) solution (1.5 M in cyclohexane) (155 mL, 1.8 equiv) in 20
min and water (2.3 mL, 1 equiv) over 10 min. The remaining
LDA (172 mL, 2 equiv) was added slowly over 4 to 5 h at between
15 and 20 °C. The reaction mixture was stirred at 25 °C for
another 4 h as monitored by HPLC. Once the reaction is
completed, 1 N hydrochloric acid (1.2 L) was added to precipitate
the chiral inducing ligand as hydrochloric acid salt. The solid
was filtered and the layers were separated. The organic layer
was concentrated and the residue was separated on a silica gel
column to give 4a (95% yield and 95% ee) as a solid. Without
addition of the water into the reaction mixture the ee ranged
from 50 to 88%.
P r ep a r a tion of Nor ep h ed er in e-Ba sed Liga n d 6d . A
mixture of (1R,2S)-(-)-norephedrine (100 g) and 3,4,5-trimeth-
oxybenzaldehyde (143 g) was dissolved in ethanol (1 L). The
resulting solution was brought to a gentle reflux for 4-5 h. The
reaction mixture was then cooled with an ice batch, and sodium
borohydride (37 g) was added protionwise. The reaction mixture
was stirred at room temperature overnight. Once reduction was
completed, excess sodium borohydride was destroyed by adding
water (25 mL). The organic solvent was evaporated and the
product was extracted with ethyl acetate. The organic layer was
concentrated to give a colorless oil. The oil was dissolved in 400
mL of ethanol. To the resulting solution was added slowly
aqueous hydrobromic acid (48%, 73 mL). The precipitate was
stirred at room temperature for 1 h and filtered to give crude
6d as HBr salt. The crude salt was recrystallized in a mixture
of methanol/diethyl ether (12:1). The recrystallized salt was
converted to a free base with diluted aqueous sodium hydroxide.
The free base was extracted with toluene. The toluene was then
removed to give 114 g of 6d (87%) as a colorless oil. 1H NMR
(CDCl3) δ 7.25-7.33 (m, 5H), 6.56 (s, 2H), 4.80 (d, J ) 3.8 Hz,
1H), 3.86 (s, 6H), 3.84 (s, 3H), 3.82 (s, 2H), 3.00 (qd, J ) 6.5, 3.8
Hz, 1H), 0.89 (d, J ) 6.5 Hz, 1H). 13C NMR (CDCl3) δ 154.3,
142.2, 139.0, 136.4, 129.1, 128.2, 127.10, 106.0, 74.4, 62.0, 59.1,
Ack n ow led gm en t. We thank Mr. Zhixing Ding, Dr.
Mingsheng Huang, J ie Xie, and Ms. J acqueline Klug for
their help on this project and Drs. Doris Schumacher
and Michael Mitchell for their support and proof-reading
of the manuscript.
Su p p or tin g In for m a tion Ava ila ble: Copies of 1H and 13C
NMR spectra for compounds 2a ,b,c, 4a , 4, 4-salt, 4e,f,g,
5a ,b,c, 6a ,b,c,d ,e, 8, and Lonafarnib and a chiral HPLC
chromatogram for 4a . This material is available free of charge
J O034380T
J . Org. Chem, Vol. 68, No. 12, 2003 4987